Vitamin D in inflammatory bowel disease: Biological, clinical and therapeutic aspects.
CONCLUSION: Well-designed intervention studies are needed in IBD, with probably higher objective plasma doses of vitamin D to establish its efficacy as a therapeutic agent with immunomodulatory properties. Meanwhile, vitamin D deficiency should be screened for and corrected in affected patients in order to achieve adequate bone and phosphocalcic metabolism.
PMID: 31109269 [PubMed - as supplied by publisher]
Source: Current Drug Metabolism - Category: Drugs & Pharmacology Authors: Olmedo-Martín RV, González-Molero I, Olveira G, Amo-Trillo V, Jiménez-Pérez M Tags: Curr Drug Metab Source Type: research
More News: Drugs & Pharmacology | Epidemiology | Inflammatory Bowel Disease | Study | Vitamin D | Vitamin D Deficiency | Vitamins